NCT01200485 2020-01-31Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2M.D. Anderson Cancer CenterPhase 2 Completed55 enrolled 11 charts
NCT00513474 2017-05-25Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell TransplantMassachusetts General HospitalPhase 1 Completed46 enrolled 11 charts
NCT00057811 2014-09-19Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or LymphomaChildren's Oncology GroupPhase 2 Completed97 enrolled 13 charts
NCT00628628 2013-08-01Rasburicase in Patients at Risk for Tumor Lysis SyndromeM.D. Anderson Cancer CenterPhase 2 Completed82 enrolled 6 charts
NCT00230178 2010-01-12Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis SyndromeSanofiPhase 3 Completed280 enrolled 10 charts